- Home
- DIBS vs ENLV Comparison
DIBS vs ENLV Comparison
Compare DIBS & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DIBS | ENLV |
|---|---|---|
| Founded | 2000 | 2005 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.7M | 196.2M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | DIBS | ENLV |
|---|---|---|
| Price | $4.45 | $0.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $7.00 | ★ $20.00 |
| AVG Volume (30 Days) | 171.2K | ★ 283.0K |
| Earning Date | 05-08-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.45 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $89,620,000.00 | N/A |
| Revenue This Year | $3.12 | N/A |
| Revenue Next Year | $1.72 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.54 | N/A |
| 52 Week Low | $2.35 | $0.66 |
| 52 Week High | $6.62 | $2.10 |
Technical Indicators
Market Signals| Indicator | DIBS | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 36.95 | 35.03 |
| Support Level | $4.38 | $0.66 |
| Resistance Level | $5.74 | $1.23 |
| Average True Range (ATR) | 0.33 | 0.06 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 50.75 | 15.23 |
Price Performance
Historical ComparisonAbout DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The company has a single reportable and operating segment that contains one reporting unit, which consists of the company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.